| |
IDUs - HCV DAA High Adherence 90% & SVR Among IDUs at Buffalo Clinic
|
| |
| |
VARIABLE ADHERENCE TO HCV TREATMENT AMONG PEOPLE WHO INJECT DRUGS TREATED WITH 8 VERSUS 12 WEEKS OF ANTIVIRAL THERAPY RESULTED IN HIGH RATES OF SVR12 AND REINFECTION RATE WAS LOW
AASLD Nov 2022
Tiberiu Moga, Gastroenterology, Hepatology and Nutrition, University at Buffalo, the State University of New York, Naren Nallapeta, Internal Medicine, University at Buffalo and Anthony Martinez, Division of Gastroenterology, Hepatology & Nutrition, University at Buffalo
| |
| |
| |
|
|
|
